LAUSR

Chronic kidney disease (CKD) is an increasingly identified complication of diabetes (1). The occurrence of CKD in a person with type 1 diabetes mellitus (T1DM or type 2 diabetes mellitus (T2DM) creates an added challenge for the diabetes care provider. Increased risk of drug-related adverse events, including hypoglycemia, possibility of drug-drug interactions, and the need to minimize associated complications, all contribute to the complexity of managing diabetes and CKD (2). This clinical situation also increases the responsibility of the treating physician, as it becomes imperative to preserve renal function while ensuring glycemic control.